Long-term follow-up of children who underwent severe hypospadias repair using an online survey with validated questionnaires

2014 ◽  
Vol 10 (3) ◽  
pp. 446-450 ◽  
Author(s):  
Sarah A. Fraumann ◽  
Heidi A. Stephany ◽  
Douglass B. Clayton ◽  
John C. Thomas ◽  
John C. Pope ◽  
...  
2020 ◽  
Vol 19 ◽  
pp. e371
Author(s):  
W. Verla ◽  
F. Van Nieuwenhuyse ◽  
A. Spinoit ◽  
M. Waterloos ◽  
M. Waterschoot ◽  
...  

2016 ◽  
Vol 118 (3) ◽  
pp. 451-457 ◽  
Author(s):  
Gina M. Cambareri ◽  
Michael Yap ◽  
George W. Kaplan

2010 ◽  
Vol 63 ◽  
pp. 125-128
Author(s):  
Joerg Seibold ◽  
Bastian Amend ◽  
Saladin H. Alloussi ◽  
Daniela Colleselli ◽  
Tilman Todenhoefer ◽  
...  

Urology ◽  
2020 ◽  
Vol 143 ◽  
pp. 248-254
Author(s):  
Wesley Verla ◽  
Féline Van Nieuwenhuyse ◽  
Piet Hoebeke ◽  
Willem Oosterlinck ◽  
Céline Sinatti ◽  
...  

2010 ◽  
Vol 183 (4S) ◽  
Author(s):  
Richard Ashley ◽  
Ahmed BaniHani ◽  
Julia Barthold ◽  
T. Ernesto Figueroa

2020 ◽  
Author(s):  
Anuj Bhatia ◽  
Jamal Kara ◽  
Tahir Janmohamed ◽  
Atul Prabhu ◽  
Gerald Lebovic ◽  
...  

BACKGROUND Chronic pain imposes a large burden on individuals and society. A patient-centric digital chronic pain management app called Manage My Pain (MMP) can be used to enhance communication between providers and patients and promote self-management. OBJECTIVE The purpose of this study was to evaluate the real-world engagement of patients in urban and rural settings in Ontario, Canada with the MMP app alongside their standard of care and assess the impact of its usage on clinical outcomes of pain and related mental health. METHODS A total of 246 participants with chronic pain at a rural and 2 urban pain clinics were recruited into this prospective, open-label, exploratory study that compared the use of MMP, a digital health app for pain that incorporates validated questionnaires and provides patients with summarized reports of their progress in combination with standard care (app group), against data entered on paper-based questionnaires (nonapp group). Participants completed validated questionnaires on anxiety, depression, pain catastrophizing, satisfaction, and daily opioid consumption up to 4.5 months after the initial visit (short-term follow-up) and between 4.5 and 7 months after the initial visit (long-term follow-up). Engagement and clinical outcomes were compared between participants in the two groups. RESULTS A total of 73.6% (181/246) of the participants agreed to use the app, with 63.4% (111/175) of them using it for at least one month. Individuals who used the app rated lower anxiety (reduction in Generalized Anxiety Disorder 7-item questionnaire score by 2.10 points, 95% CI –3.96 to –0.24) at short-term follow-up and had a greater reduction in pain catastrophizing (reduction in Pain Catastrophizing Scale score by 5.23 points, 95% CI –9.55 to –0.91) at long-term follow-up relative to patients with pain who did not engage with the MMP app. CONCLUSIONS The use of MMP by patients with chronic pain is associated with engagement and improvements in self-reported anxiety and pain catastrophizing. Further research is required to understand factors that impact continued engagement and clinical outcomes in patients with chronic pain. CLINICALTRIAL ClinicalTrials.gov NCT04762329; https://clinicaltrials.gov/ct2/show/NCT04762329


Sign in / Sign up

Export Citation Format

Share Document